Analyst Consensus
- Current Price
- 334.28 $
- Target (Low)
- 310.00 $
- Target (Mean)
- 370.18 $
- Target (High)
- 430.00 $
- Recommendation
- Buy
- Number of Analysts
- 33
Recommendation Distribution
Recommendation Distribution| Strong Buy | 4 |
|---|
| Buy | 18 |
|---|
| Hold | 14 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 8.4%
- Operating Margin
- 11.9%
- Gross Margin
- 33.1%
- Return on Equity (ROE)
- 128.4%
- Return on Assets (ROA)
- 12.5%
- Revenue Growth
- 4.8%
- Earnings Growth
- -4.3%
- Debt/Equity
- 459.36
- Current Ratio
- 1.05
- Beta
- 0.97
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 20, 2026 | Piper Sandler | Overweight → Overweight |
| May 20, 2026 | Truist Securities | Buy → Buy |
| May 20, 2026 | UBS | Buy → Buy |
| May 20, 2026 | TD Cowen | Buy → Buy |
| May 20, 2026 | RBC Capital | Sector Perform → Sector Perform |
| May 20, 2026 | DA Davidson | Buy → Buy |